GAITHERSBURG, Md., Aug. 04, 2020 (GLOBE NEWSWIRE) — Emergent BioSolutions Inc. (NYSE:EBS) (the “Company”) announced today that it intends to offer $400 million aggregate principal amount of senior unsecured notes with an expected maturity date of August 2028 (the “Notes”). The Notes will be fully and unconditionally guaranteed on a senior unsecured basis by all of the Company’s direct and indirect subsidiaries that guarantee debt under its credit facilities. The Company intends to use the net proceeds of the offering to repay the $353 million outstanding under its $600 million revolving credit facility with the remainder to be used for general corporate purposes.
{iframe}https://www.globenewswire.com/news-release/2020/08/04/2072437/0/en/Emergent-BioSolutions-Announces-Proposed-Offering-of-400-Million-of-Senior-Unsecured-Notes.html{/iframe}